Alex Dorr Email & Phone Number

Zurich, Switzerland

North Chicago, Illinois, Us

In this current role, I spearhead R&D approach across global, area, and local levels by utilizing diverse team of pipeline Medical Science Liaisons to foster scientific discourse and bolster patient recruitment by 30% in key clinical trials. I utilize field intelligence to refine study protocols and elevate patient care standards. I collaborate on Continued Treatment for Trial Participants (CTTP) team, earning 2024 R&D President Award and facilitating public release of CTTP policy on abbvie.com and its inclusion in 2024 ESG reportKey Successes:• Engaged with Medical Affairs Therapeutic Area and regional VPs, achieving a 70% expansion of the global in-field team.• Established a robust Medical Affairs division by managing a team of over 80 HQ and in-field professionals.

North Chicago, Illinois, Us

I developed strategic medical affairs capabilities, including evidence gap analysis, medical education initiatives, and clinical development support. I ensured internal audit compliance and external inspection readiness as co-leader of the Medical, Legal, OEC, and Regulatory team. I facilitated early access and compassionate use programs by enhancing patient care and treatment availability.Key Successes:• Represented the organization at high-level governmental and public conferences, advocating for medical/scientific interests.• Directed Medical Affairs team for Europe South by managing workforce of over 140 full-time employees and orchestrating research and development budget across six nations.

North Chicago, Illinois, Us

During this tenure, I managed diverse team of medical affairs professionals across Western Europe and Canada, overseeing strategic initiatives in immunology therapeutic area. I implemented innovative in-field capabilities, including scientific communication ladders, to enhance engagement and knowledge dissemination. I redesigned medical team structure to align with commercial strategies, introducing new area brand team framework. I fostered cross-functional collaboration by driving integrity in pharmaceutical practices and patient access to investigational medicines post-trial.Key Successes:• Orchestrated transition and organizational adaptation in response to HUMIRA's loss of exclusivity by ensuring launches for SKYRIZI and RINVOQ.• Started work on global policy to facilitate continued patient access to investigational medicines by ensuring treatment continuity. • Provided indirect leadership to medical affairs team of over 220 FTE, overseeing their strategic work and budget allocation to advance immunology research and development.

North Chicago, Illinois, Us

I oversaw medical affairs strategy and operations including pharmacovigilance, quality assurance, and compliance with labor laws by ensuring affiliate's adherence to industry standards. I authorized interventional Clinical Study Agreements by reinforcing affiliate's commitment to research excellence and patient safety.Key Successes:• Supervised multifaceted medical team of 45 professionals by enhancing their impact within organization and advancing affiliate's strategic objectives.• Involved in high-stakes negotiations on product pricing with Austrian Association of Social Security, contributing to affiliate's financial stability.

North Chicago, Illinois, Us

I orchestrated strategic planning and execution of medical affairs initiatives by ensuring alignment with global objectives. I cooperated with cross-functional teams to enhance product knowledge and therapeutic area leadership. I advocated for patient access to investigational medicines post-trial, contributing to ethical medical practice and patient care.Key Successes:• Specialized in leading rheumatology and uveitis-related medical activities and launches across Western Europe and Canada.

North Chicago, Illinois, Us

I headed strategic initiatives as Associate Director at GMA Rheumatology, focusing on Spondyloarthritis (SpA) co-indication leadership and advancing global medical affairs. I advanced educational events at key scientific congresses (EULAR, ACR) to enhance understanding of rheumatologic conditions.Key Successes:• Spearheaded LOOP study development, an international observational study across 17 countries, enrolling over 1400 patients. • Represented organization as GMA lead during 2013 FDA Advisory Committee meeting on non-radiographic-axial SpA, influencing regulatory outcomes.

We established this non-profit shareholder company in order to provide the financial funding necessary to acquire and renovate the local supermarket and coffee shop, which is currently being exploited by the Coopérative de Chandolin. The investment of our shareholders in this company is a testimony to the support of the long-term development of our remote mountain village located in the Swiss Valaisan Alps.

Basel, Ch

Development and execution of global scientific communication strategy and plans for development (almorexant, ponesimod, cadazolid) and launch/launched assets (bosentan, macitentan, selexipag).

Darmstadt, Hessen, De

Managing Medical Communication Information Team for fertility (Gonal-f®, Luveris®, Ovidrel®, Pergoveris®), cardiometabolic care (Glucophage®, Concor®, Euthyrox®) and cancer (Erbitux®)Development and execution of Global Medical Affairs communication Strategy (CME, symposia, publications) for marketed and products in development:o Raptiva® (efalizumab), atacicept, FGF-18 o Scientific assessment of investigator-sponsored trialso Medical review and approval of marketing materialso Planning and execution of international advisory boards o Creation of early scientific platforms for products atacicept (rheumatoid arthritis, multiple sclerosis, lupus, cancer) and osteoarthritis (FGF 18)Brand and Global Product Team member for globally marketed and products in developmentPersonalized External Expert managementLine-managerial responsibility and team leadership developmentTenacious agency management and budgeting

Locum Assistant Editor at Nature Structural & Molecular BiologyEvaluation of scientific projectsPublication of short editorial summaries

Lausanne, Vaud, Ch

Scientific Assistant to Prof. TronoContinuation of a genomic HIV project - initiated at the University of Geneva (lab move).

Genève, Ch

Assistant to Prof. TronoHIV immunology, initiation of a HIV genomic project

Heidelberg, De

PhD thesis on HIV transcription.Cross-functional scientific project in virology, immunology, and chromatin biology.

Master Of Science, Biology

Phd, Life Science

Master'S Degree, Life Science

Master Of Science, Immunology